Clinical trial
Utility Of Mutational Load As A Predictor For Endoscopic Treatment Response In Barrett's Esophagus
NCT04316975 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Utility Of Mutational Load As A Predictor For Endoscopic Treatment Response In Barrett's Esophagus
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 10, 2020
- Completion date
- December 20, 2023
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
barretts esophagus with dysplasia, intramucosal adenocarcinoma